Free Trial

Lipella Pharmaceuticals (LIPO) SEC Filings & 10K Form

Lipella Pharmaceuticals logo
$2.40 -0.01 (-0.41%)
Closing price 04/17/2025 03:59 PM Eastern
Extended Trading
$2.40 0.00 (0.00%)
As of 04/17/2025 04:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Lipella Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/14/2025
5:08 AM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2025
7:39 PM
Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
04/09/2025
7:43 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
04/09/2025
4:06 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/07/2025
6:16 PM
Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
6:20 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
04/07/2025
5:05 AM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2025
4:14 PM
Lipella Pharmaceuticals (Filer)
Form 424B5
04/03/2025
11:15 PM
Lipella Pharmaceuticals (Filer)
Form EFFECT
03/28/2025
5:21 AM
Lipella Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/27/2025
6:56 PM
Lipella Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/19/2025
5:23 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
03/18/2025
4:01 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/17/2025
7:18 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
03/17/2025
7:12 PM
Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:01 PM
Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
7:09 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
03/11/2025
4:26 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/24/2025
3:05 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2025
8:28 AM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2025
4:32 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
02/10/2025
4:35 PM
Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
01/30/2025
4:27 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
01/30/2025
4:28 PM
Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
01/23/2025
5:08 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
01/23/2025
5:11 PM
Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
01/17/2025
7:13 PM
Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
7:17 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
01/16/2025
5:51 AM
Lipella Pharmaceuticals (Filer)
Form 424B3
01/15/2025
11:15 PM
Lipella Pharmaceuticals (Filer)
Form EFFECT
01/13/2025
7:42 AM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
4:25 PM
Lipella Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/07/2025
4:28 PM
Lipella Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
01/06/2025
4:25 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2025
8:22 PM
Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
8:25 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
12/30/2024
3:11 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2024
8:28 PM
Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
8:31 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
12/27/2024
3:05 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2024
8:29 AM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
The Trump Dump is starting; Get out of stocks now? (Ad)

The first 365 days of the Trump presidency… Will be the best time to get rich in American history.

If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a
11/14/2024
4:26 PM
Lipella Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
4:01 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2024
4:24 PM
Lipella Pharmaceuticals (Filer)
Form PRE 14A
11/01/2024
4:00 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2024
3:05 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
4:00 PM
Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
Form SC 13D/A
10/17/2024
4:00 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SC 13D/A
09/11/2024
4:10 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2024
3:05 PM
Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
Form SC 13D/A
08/13/2024
3:13 PM
Lipella Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2024
7:44 AM
Lipella Pharmaceuticals (Filer)
Form ARS
08/12/2024
7:25 AM
Lipella Pharmaceuticals (Filer)
Form DEF 14A
08/06/2024
3:50 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
4:20 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
10:50 AM
Lipella Pharmaceuticals (Filer)
Form 424B5
05/15/2024
3:39 PM
Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
3:15 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:LIPO) was last updated on 4/20/2025 by MarketBeat.com Staff
From Our Partners